FACT FINDERS: How Novavax Differs From Other COVID-19 Vaccines June 14, 2021 The Novavax vaccine differs from other Covid-19 vaccines because it already has the spike protein of the virus but it cannot cause the actual disease. ”I would love to see that vaccine here, it’s much more easily stored and transported, it would make it a lot easier to get that type of vaccine out to the rest of the world as well,” said Deepta Bhattacharya, an immunobiologist at the College of Medicine – Tucson. KOLD-TV (Tucson, AZ)
Minding Melanoma: Prevention and Disparities Among People of Color June 14, 2021 While Caucasions are 20 times more likely to develop melanoma than people of color, the reality is when it's diagnosed in people of color it’s typically in the deadliest of stages. "The rate for melanoma is now 30 per 100,000 in Arizona compared to 22.7 per 100,000 in the United States as a whole," said Robin Harris, a professor at the Mel and Enid Zuckerman College of Public Health and co-director of the Skin Cancer Institute at the UArizona Cancer Center. KGUN-TV (Tucson, AZ)
UA Researchers Will Study Border Children to See What Role Germs Play in Asthma Rates June 13, 2021 A $15.3 million grant will fund research to study Hispanic children’s susceptibility to asthma in Tucson, compared to Nogales, Sonora, where it is much less prevalent. “We have a very significant asthma epidemic in the United States, and many children who develop asthma can be burdened for a lifetime. My goal is to prevent asthma in children by building their immune system,” said Dr. Fernando Martinez, director of the UArizona Health Sciences Asthma and Airway Disease Research Center. Arizona Daily Star
Stem Cell Studies Take Time, But Arizona Researchers Say the Wait is Safer for Patients June 13, 2021 David Harris, professor of immunobiology and executive director of the UArizona Biorepository in the College of Medicine – Tucson, believes that stem cell clinics marketing unproven treatments could hurt researchers who are doing things the correct way. "If it appears that medical professionals are doing this just to make money, it will spur a lot of distrust, not only in the doctors, but also in in this field," said Harris. The Arizona Republic
Despite Risks, Opioid Users More Likely to Receive Sedating Medications June 11, 2021 New data presented at the annual SLEEP meeting of the Associated Professional Sleep Societies suggests that individuals who used or abused opioids were significantly more likely to receive sedating medications than those who did not use opioids. “At least 9% of the individuals using an opioid had also used a sedating medication despite the increased risk for overdose death with combined use," said Andrew S. Tubbs, an MD/PhD student at the College of Medicine – Tucson. Healio
Valley Fever Center for Excellence Celebrates 25 Years June 10, 2021 The center focuses on research, outreach and education to fulfill its mission of protecting people against a deadly fungal disease native to the Southwest. Read more Image
Valley Fever Case Count Jumps June 10, 2021 Dr. John Galgiani, a professor of medicine in infectious diseases at the College of Medicine – Tucson and director of the Valley Fever Center for Excellence, says this year Valley Fever is heading for the highest case count in the last ten years. KGUN-TV (Tucson, AZ)
We Know Vaccines Are Working Against New COVID Variants. Now Scientists Are Starting to Understand Why. June 10, 2021 In an article for ABC News, Dr. Onyema Okolo, an oncologist and hematologist from the University of Arizona Cancer Center, discusses how and why the Covid-19 vaccines are working against variants. Dr. Okolo is a contributor to the ABC News Medical Unit. ABC News
Janelle's Journey: Arizona Woman Hoped to Heal Through Stem Cell Treatments June 10, 2021 David Harris, professor of immunobiology and executive director of the UArizona Biorepository in the College of Medicine –Tucson, said there is some encouraging data to support the ability of mesenchymal stem cells to treat various conditions such as an open wound. Harris also said there's no conclusive scientific proof yet that they work and that studies are still ongoing. The Arizona Republic
Cost-Effectiveness of Adjunctive Osimertinib for EGFR-Positive NSCLC June 10, 2021 Briana Choi, a PhD student at the College of Pharmacy, discusses the cost evaluation of osimertinib use as an adjunctive maintenance therapy in surgically resected EGFR-positive non-small cell lung cancer. The findings were presented at the virtual 2021 ASCO Annual Meeting. Journal of Clinical Pathways